Neuvotion has revealed an expansion of their partnership with Intelligent Product Solutions (IPS) as they work towards launching their neurostimulation product. This partnership includes a private investment from IPS’s parent organization, Forward Industries, intended to accelerate the introduction of their initial product, NeuStim, to the market. Based in Stamford, Connecticut, Neuvotion specializes in creating neuromodulation solutions targeting neurorehabilitation, brain-computer interface (BCI), and physical therapy sectors. Their innovations aim to assist patients in regaining movement and sensation, particularly those affected by strokes or spinal cord injuries (SCI). Neuvotion’s technology uniquely combines precise neurostimulation with AI to bolster rehabilitation efforts, aiming to make physical and occupational therapies more efficient and result-driven. This leads to better patient outcomes, independence, and quality of life, according to Chad Bouton, the company’s founder and CEO. Bob Wild, COO of Intelligent Product Solutions, expressed enthusiasm at aiding Neuvotion in advancing within the evolving neuromodulation and neurorehabilitation fields. He praised NeuStim as an innovative solution poised to enhance recovery experiences for stroke and spinal cord injury patients. “Our multidisciplinary team at IPS, made up of designers, engineers, and scientists, is excited to lend our medical device development and engineering proficiency as Neuvotion readies their transformational technologies for the market,” he stated.
Menu
Menu